Jones Trading Upgrades Beam Therapeutics to Buy, Announces $34 Price Target

Benzinga · 03/10 19:15
Jones Trading analyst Soumit Roy upgrades Beam Therapeutics (NASDAQ:BEAM) from Hold to Buy and announces $34 price target.